In the pre-thrombolytic era, second-or third-degree AV block was recorded in 5% to 7% of patients presenting with acute MI (2,3), and reached 28% in those with inferior MI (4). In the thrombolytic era, Meine et al. (5) reported that the overall incidence was little changed at 6.9% with inferior MI; age, worse Killip class at presentation, female sex, smoking, hypertension, and diabetes were all risk factors for its occurrence. In that study, adjusted 1-year mortality was significantly higher in patients with than in those without AV block (odds ratio [OR]: 1.5; 95% confidence interval [CI]: 1.3 to 1.6), and when subdivided by location, the ORs for death were 2.4 (95% CI: 2.2 to 2.6) and 3.3 (95% CI: 3.0 to 3.7) for inferior and anterior MI, respectively. One problem with both older and more recent data is that a distinction is not made between second-and third-degree AV block. Why is CHB with STEMI increasing when cardiac care has improved and mortality decreased (7)? There are several possible explanations. First, the time point of reference must be considered: despite the increasing trend of CHB in the current study, the rate is still much less than that in the pre-thrombolytic era (3) (4) (5) 8) , and as discussed by Harikrishnan et al. (6), this likely reflects overall improvement in MI care.
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A third point for discussion is that because CHB continues to be a problem, how should it be managed in an era when implantable cardioverter-defibrillators Because CHB has not gone away, Harikrishan et al.
(6) have given us new information, food for thought, for which we should be grateful. In the "old days" it was said that although patients with inferior MI who developed AV block had poor in-hospital outcomes, long-term prognosis was similar irrespective of its occurrence (17) , even for those with CHB (18). However, patients with anterior MI and CHB did not fare as well in the past (3), or today as in the current study.
As the investigators point out, CHB with STEMI was associated with a 20.4% increase in mortality, twice that seen in patients without CHB. New initiatives can be envisioned to identify high-risk subsets with a
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